Akamis Bio is based in Cambridge, MA. It has raised $90M in total funding. Latest round: Series A.
Akamis Bio funding overview
Akamis Bio is based in Cambridge, MA. Akamis Bio has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2023. The round record for Akamis Bio runs through 2023; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners, Sedgwick Yard. 4 distinct backers are named across the disclosed rounds.
Akamis Bio at a glance
Total raised
$90M
Latest round
Series A
Latest round date
December 2023
Headquarters
Cambridge, MA
Notable investors
ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners, Sedgwick Yard
Frequently asked about Akamis Bio funding
How much has Akamis Bio raised?
Akamis Bio has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Akamis Bio?
ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners, Sedgwick Yard are named among the investors backing Akamis Bio.
What was the latest Akamis Bio funding round?
The most recent disclosed round is a Series A, announced in December 2023.
Where is Akamis Bio based?
Akamis Bio is based in Cambridge, MA.
When did Akamis Bio last raise?
The last disclosed Akamis Bio round closed in December 2023 at Series A.
Totals shown for Akamis Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
